A Change in Oxygen Supplementation Can Decrease the Incidence of Retinopathy of Prematurity

Ophthalmology

Volumn 116, Issue 3, 2009, Pages 513-518

  Sears, Jonathan E ^a   Pietz, Jeffrey ^b   Sonnie, Christine ^a   Dolcini, David ^b   Hoppe, George ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b FAIRVIEW HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ARTICLE; BIRTH WEIGHT; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DEVELOPMENTAL STAGE; EYE FUNDUS; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; OXYGEN SATURATION; OXYGEN SUPPLY; OXYGEN THERAPY; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE DATABASE; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; RISK REDUCTION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

BIRTH WEIGHT; CHILD, PRESCHOOL; FEMALE; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; OXYGEN; OXYGEN CONSUMPTION; OXYGEN INHALATION THERAPY; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES;

EID: 61349125462     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.09.051     Document Type: Article

References (25)

1. Terry T.L. Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: II. Report of cases-clinical aspects. Trans Am Ophthalmol Soc 40 (1942) 262-284
2. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach. Med J Aust 2 (1951) 48-50
3. Crosse V.M., and Evans P.J. Prevention of retrolental fibroplasia. AMA Arch Ophthalmol 48 (1952) 83-87
4. Patz A., Hoeck L.E., and De La Cruz E. Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol 35 (1952) 1248-1253
5. Kinsey V.E. Retrolental fibroplasia; cooperative study of retrolental fibroplasia and the use of oxygen. AMA Arch Ophthalmol 56 (1956) 481-543
6. Phelps D.L. Retinopathy of prematurity. Pediatr Rev 16 (1995) 50-56
7. Good W.V., and Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102 (2004) 233-250
8. Sears J.E., and Sonnie C. Anatomic success of lens-sparing vitrectomy with and without scleral buckle for stage 4 retinopathy of prematurity. Am J Ophthalmol 143 (2007) 810-813
9. Lakhanpal R.R., Sun R.L., Albini T.A., et al. Visual outcomes after 3-port lens-sparing vitrectomy in stage 4 retinopathy of prematurity. Arch Ophthalmol 124 (2006) 675-679
10. Hubbard III G.B., Cherwick D.H., and Burian G. Lens-sparing vitrectomy for stage 4 retinopathy of prematurity. Ophthalmology 111 (2004) 2274-2277
11. Prenner J.L., Capone Jr. A., and Trese M.T. Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity. Ophthalmology 111 (2004) 2271-2273
12. Lutty G.A., Chan-Ling T., Phelps D.L., et al. Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). Mol Vis [serial online] 2006;12:532-80. http://www.molvis.org/molvis/v12/a63/ Accessed September 8, 2008
13. Flynn J.T., Bancalari E., Snyder E.S., et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med 326 (1992) 1050-1054
14. Alon T., Hemo I., Itin A., et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1 (1995) 1024-1028
15. Pierce E.A., Foley E.D., and Smith L.E. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 114 (1996) 1219-1228
16. Penn J.S., Henry M.M., Wall P.T., and Tolman B.L. The range of Pa02 variation determines the severity of oxygen-induced retinopathy in newborn rats. Invest Ophthalmol Vis Sci 36 (1995) 2063-2070
17. Aiello L.P. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic Res 29 (1997) 354-362
18. Semenza G.L. Life with oxygen. Science 318 (2007) 62-64
19. Chow L.C., Wright K.W., Sola A., and CSMC Oxygen Administration Study Group. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?. Pediatrics 111 (2003) 339-345
20. Palmer E.A. Results of U.S. randomized clinical trial of cryotherapy for ROP (CRYO-ROP). Doc Ophthalmol 74 (1990) 245-251
21. STOP-ROP Multicenter Study Group. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 105 (2000) 295-310
22. Tin W., Milligan D.W., Pennefather P., and Hey E. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed 84 (2001) F106-F110
23. Haynes R.L., Folkerth R.D., Keefe R.J., et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 62 (2003) 441-450
24. Collins M.P., Lorenz J.M., Jetton J.R., and Paneth N. Hypocapnia and other ventilation-related risk factors for cerebral palsy in low birth weight infants. Pediatr Res 50 (2001) 712-719
25. Askie L.M., Henderson-Smart D.J., Irwig L., and Simpson J.M. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 349 (2003) 959-967